Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physical Activity Plus Dexamethasone for Cancer-Related Fatigue in Advanced Cancer
NCT02491632Phase 3Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2015
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in cancer-related fatigue (CRF), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2015; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT02491632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491632.